The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

The FDA is proposing a limit on the amount of nicotine in cigarettes and certain other combustible tobacco products to reduce ...

For MarComm leaders, this is a moment to lead by example—aligning marketing practices with broader societal objectives.

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some questions linger. Experts explain the efficacy and potential health risks of nicot ...

This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...

In a statement published Jan. 16, the agency stated that 20 different Zyn nicotine pouch products can now be marketed to adults ages 21 and over.That doesn't mean the pouches are now "FDA approved ...

The FDA determined that due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, the authorized nicotine pouches pose a lower risk for cancer ...

The U.S. Food and Drug Administration (FDA) has approved the marketing of 20 ZYN nicotine pouch products after a thorough scientific evaluation through the premarket tobacco product application ...